O'Donoghue J - Search Results

1

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

Behling K, Maguire WF, López Puebla JC, Sprinkle SR, Ruggiero A, O'Donoghue J, Gutin PH, Scheinberg DA, McDevitt MR. Behling K, et al. J Nucl Med. 2016 Oct;57(10):1576-1582. doi: 10.2967/jnumed.115.171371. Epub 2016 Apr 28. J Nucl Med. 2016. PMID: 27127217 Free PMC article.

2

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.

O'Donoghue JA, Bardiès M, Wheldon TE. O'Donoghue JA, et al. J Nucl Med. 1995 Oct;36(10):1902-9. J Nucl Med. 1995. PMID: 7562062 Free article.

3

Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients.

Loh A, Sgouros G, O'Donoghue JA, Deland D, Puri D, Capitelli P, Humm JL, Larson SM, Old LJ, Divgi CR. Loh A, et al. J Nucl Med. 1998 Mar;39(3):484-9. J Nucl Med. 1998. PMID: 9529296 Free article. Clinical Trial.

4

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

Divgi CR, Bander NH, Scott AM, O'Donoghue JA, Sgouros G, Welt S, Finn RD, Morrissey F, Capitelli P, Williams JM, Deland D, Nakhre A, Oosterwijk E, Gulec S, Graham MC, Larson SM, Old LJ. Divgi CR, et al. Clin Cancer Res. 1998 Nov;4(11):2729-39. Clin Cancer Res. 1998. PMID: 9829736 Clinical Trial.

5

Implications of nonuniform tumor doses for radioimmunotherapy.

O'Donoghue JA. O'Donoghue JA. J Nucl Med. 1999 Aug;40(8):1337-41. J Nucl Med. 1999. PMID: 10450686 Free article.

6

131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.

Barendswaard EC, O'Donoghue JA, Larson SM, Tschmelitsch J, Welt S, Finn RD, Humm JL. Barendswaard EC, et al. J Nucl Med. 1999 Oct;40(10):1764-8. J Nucl Med. 1999. PMID: 10520720 Free article.

7

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

O'Donoghue JA, Sgouros G, Divgi CR, Humm JL. O'Donoghue JA, et al. J Nucl Med. 2000 Mar;41(3):538-47. J Nucl Med. 2000. PMID: 10716330 Free article.

8

Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.

Ruan S, O'Donoghue JA, Larson SM, Finn RD, Jungbluth A, Welt S, Humm JL. Ruan S, et al. J Nucl Med. 2000 Nov;41(11):1905-12. J Nucl Med. 2000. PMID: 11079503 Free article.

9

Hypoxia-Induced increase in FDG uptake in MCF7 cells.

Burgman P, Odonoghue JA, Humm JL, Ling CC. Burgman P, et al. J Nucl Med. 2001 Jan;42(1):170-5. J Nucl Med. 2001. PMID: 11197971 Free article.

10

Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft.

Barendswaard EC, Humm JL, O'Donoghue JA, Sgouros G, Finn RD, Scott AM, Larson SM, Welt S. Barendswaard EC, et al. J Nucl Med. 2001 Aug;42(8):1251-6. J Nucl Med. 2001. PMID: 11483688 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters